News, Links and Commentary
Monday, September 08, 2003
Genaera's Squalamine Shows Promise as a Treatment for Wet AMD
'Genaera Reports Squalamine Improves Vision in Age-Related Macular Degeneration' (August 4, 2003, PRNewswire). This press release from Genaera announces that the drug squalamine was found to improve the vision of patients with the wet form of age-related macular degeneration.
The release states that squalamine was administered "for the treatment of choroidal neovascularization associated with age-related macular degeneration (AMD), also known as “wet” AMD." I haven't read about the two forms of AMD for some time and so double checked that there are both wet and dry forms can be age related. What Causes Macular Degeneration? (from the Schepens Eye Research Institute's Macular Degeneration Fact Sheet) clarified this for me. Although the dry form is more common, the wet form is more likely to cause legal blindness.
The release states that squalamine was administered "for the treatment of choroidal neovascularization associated with age-related macular degeneration (AMD), also known as “wet” AMD." I haven't read about the two forms of AMD for some time and so double checked that there are both wet and dry forms can be age related. What Causes Macular Degeneration? (from the Schepens Eye Research Institute's Macular Degeneration Fact Sheet) clarified this for me. Although the dry form is more common, the wet form is more likely to cause legal blindness.
Comments:
Post a Comment
